Literature DB >> 1814167

Significance and assessment of autonomic indices in cardiovascular reactions.

E Láng1, N Szilágyi.   

Abstract

The purpose of this review was to integrate recent evidence supporting the reliability of noninvasive measures of parasympathetic and sympathetic activity. Literature concerning spectral analysis of heart period (HP) variability is reviewed with special emphasis on works revealing neural mediation of high-frequency and mid-frequency components of HP power spectrum and suggesting their use as a tool to assess autonomic balance. Problems of derivations of autonomic indices based on impedance cardiography and HP variance analysis are discussed. Advantages of parametric time series (autoregressive-AR) models are described with the objective of providing an informed basis for choosing among methodological alternatives. Two original approaches developed in our laboratory are outlined, namely the algorithms for systolic time interval assessment based on impedance cardiogram as well as the AR method developed for heart period power spectral density estimation.

Mesh:

Year:  1991        PMID: 1814167

Source DB:  PubMed          Journal:  Acta Physiol Hung        ISSN: 0231-424X


  3 in total

1.  5-HT3 receptor antagonists regulate autonomic cardiac dysfunction in primary fibromyalgia syndrome.

Authors:  Matthias F Seidel; Gunter F Weinreich; Thomas Stratz; Wolfgang Müller
Journal:  Rheumatol Int       Date:  2007-07-19       Impact factor: 2.631

2.  Assessing the Relationship Between Emotional States of Dogs and Their Human Handlers, Using Simultaneous Behavioral and Cardiac Measures.

Authors:  Emma K Grigg; Serene Liu; Denise G Dempsey; Kylee Wong; Melissa Bain; John J Sollers; Rani Haddock; Lori R Kogan; Jennifer A Barnhard; Ashley A Tringali; Abigail P Thigpen; Lynette A Hart
Journal:  Front Vet Sci       Date:  2022-07-11

3.  Human analogue safe haven effect of the owner: behavioural and heart rate response to stressful social stimuli in dogs.

Authors:  Márta Gácsi; Katalin Maros; Sofie Sernkvist; Tamás Faragó; Adám Miklósi
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.